Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,036 | -220,432 | -159,694 | -103,968 | -50,515 |
| Depreciation Amortization | 851 | 5,613 | 4,534 | 3,156 | 1,558 |
| Accounts receivable | 4,903 | -4,878 | 147 | -446 | -1,105 |
| Accounts payable and accrued liabilities | -557 | 4,368 | 1,674 | 1,252 | -229 |
| Other Working Capital | 6,327 | 8,176 | -3,846 | -4,366 | -11,935 |
| Other Operating Activity | 1,744 | 29,804 | 22,109 | 17,300 | 12,999 |
| Operating Cash Flow | $-35,768 | $-177,349 | $-135,076 | $-87,072 | $-49,227 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 25,107 | 118,168 | 145,072 | 55,231 | 58,619 |
| PPE Investments | -1,840 | -4,100 | -3,476 | -2,862 | -2,248 |
| Investing Cash Flow | $23,267 | $114,068 | $141,596 | $52,369 | $56,371 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 1,284 | 665 | 585 | 218 |
| Financing Cash Flow | $0 | $1,284 | $665 | $585 | $218 |
| Beginning Cash Position | 145,399 | 207,396 | 207,396 | 207,396 | 207,396 |
| End Cash Position | 132,898 | 145,399 | 214,581 | 173,278 | 214,758 |
| Net Cash Flow | $-12,501 | $-61,997 | $7,185 | $-34,118 | $7,362 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,768 | -177,349 | -135,076 | -87,072 | -49,227 |
| Capital Expenditure | -1,840 | -4,118 | -3,494 | -2,880 | -2,248 |
| Free Cash Flow | -37,608 | -181,467 | -138,570 | -89,952 | -51,475 |